DKSH Hong Kong Business Unit Healthcare has signed an MOU with Guang Yao (Zhuhai Hengqin) Pharmaceuticals Import and Export Company Limited (Guang Yao (Zhuhai Hengqin) Pharmaceuticals) to enhance healthcare expansion in the Greater Bay Area. This partnership will facilitate the cross-border flow of healthcare products and pharmaceuticals while leveraging DKSH’s market expansion expertise and Guang Yao’s presence in China.
Hong Kong, April 24, 2025 – DKSH’s Business Unit Healthcare, a strategic healthcare business partner in Asia and beyond, has recently signed the Memorandum of Understanding (MOU) with Guang Yao (Zhuhai Hengqin) Pharmaceuticals Import and Export Company Limited, marks the beginning of a strategic partnership aimed at enhancing healthcare accessibility in the Greater Bay Area (GBA).
The Greater Bay Area, comprising nine Mainland Chinese cities (Zhaoqing, Guangzhou, Huizhou, Foshan, Dongguan, Zhongshan, Shenzhen, Zhuhai, Jiangmen) along with Hong Kong and Macau. By expanding DKSH Hong Kong’s operational territory from Hong Kong and Macau to the GBA, this partnership unlocks significant business opportunities and growth potential.
As part of its commitment to optimizing supply chain capabilities, DKSH Hong Kong has also invested in the renovation of its bonded warehouse in Qianhaiwan (GBA Distribution Center). This facility has been upgraded into a cost-efficient pharmaceutical-grade warehouse, improving cost competitiveness in securing new distribution businesses and enhancing supply chain management efficiency for existing pharmaceutical clients with bulk storage needs.
“The strategic partnership with DKSH is a key milestone at Guang Yao (Zhuhai Hengqin) Pharmaceuticals to expand our businesses to Hong Kong, Macau and then South-east Asia” said Jude Zhu, General Manager, Guang Yao (Zhuhai Hengqin) Pharmaceuticals. “It fully aligns and supports our recent strategic initiatives of ‘Go South’ and ‘Internationalisation’ to grow our businesses to new heights.”
“This strategic partnership with Guang Yao (Zhuhai Hengqin) Pharmaceuticals marks a significant milestone in our efforts to expand DKSH Hong Kong's footprint in the Greater Bay Area and fulfill our purpose of enriching people’s lives by providing better healthcare for all,” said Wai Ting Fong, Vice President, Healthcare, DKSH Hong Kong. “By leveraging our market expansion expertise and Guang Yao (Zhuhai Hengqin) Pharmaceuticals' strong presence in China, we aim to create greater access to healthcare solutions for both international and China-based pharmaceutical companies, ultimately benefiting patients in the region and beyond.”
This strategic partnership between DKSH Hong Kong and Guang Yao (Zhuhai Hengqin) Pharmaceuticals signifies a major milestone in advancing healthcare accessibility and business expansion in the GBA, reinforcing DKSH’s leadership in providing market expansion services in Asia and beyond.
About Guang Yao (Zhuhai Hengqin) Pharmaceuticals Import and Export Company Limited
Guang Yao (Zhuhai Hengqin) Pharmaceuticals Import and Export Company Limited was established in 2019 as a wholly-owned subsidiary of Guangzhou Pharmaceutical Co., Ltd. (GPC). GPC, as a core enterprise in the commercial sector of the Fortune 500 company GPHL, is a large pharmaceutical commercial enterprise primarily focused on pharmaceutical supply chain services. The company mainly engages in the wholesale and retail of various pharmaceutical products and is committed to providing professional supply chain services to upstream and downstream partners in the pharmaceutical industry value chain. It is a leading pharmaceutical commercial enterprise in South China in terms of network coverage and terminal scale. As Guangzhou Pharmaceutical's platform and window for import and export business, Guang Yao Zhuhai Hengqin provides customers with one-stop services in international trade, including warehousing and logistics. www.gzmpc.com
About DKSH
For 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health, over-the-counter products and medical devices. With around 7,940 specialists, the Business Unit generated net sales of CHF 5.7 billion in 2024. www.dksh.com/hec